Skip to main content

Peer Review reports

From: Association of early PSA decline and time to PSA progression in abiraterone acetate-treated metastatic castration-resistant prostate cancer; a post-hoc analysis of Japanese phase 2 trials

Original Submission
28 Jan 2016 Submitted Original manuscript
Author responded Author comments
Reviewed Reviewer Report
Resubmission - Version 2
Submitted Manuscript version 2
Author responded Author comments
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
3 Jun 2016 Editorially accepted
8 Jun 2016 Article published 10.1186/s12894-016-0148-4

You can find further information about peer review here.

Back to article page